Search research articles
Contact Us
Filters
Showing results (741-750 of 831) with videos related to
Page
of 84
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 6, 2019
TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer
Roisin M Connolly, Jeffrey P Leal, Lilja Solnes, et al.
Radiology
|
April 1, 2025
MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial)
Kalina P Slavkova, Ruya Kang, Anum S Kazerouni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 14, 2020
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
Kimberly H Allison, M Elizabeth H Hammond, Mitchell Dowsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 2004
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004
Eric P Winer, Clifford Hudis, Harold J Burstein, et al.
Science Translational Medicine
|
June 8, 2012
A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma
Sharanya Sivanand, Samuel Peña-Llopis, Hong Zhao, et al.
Radiology
|
April 29, 2025
Erratum for: MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial)
Kalina P Slavkova, Ruya Kang, Anum S Kazerouni, et al.
Archives of Pathology & Laboratory Medicine
|
October 9, 2013
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2006
2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline
Thomas J Smith, James Khatcheressian, Gary H Lyman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2005
American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer
Gary H Lyman, Armando E Giuliano, Mark R Somerfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 6, 2021
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group
Roisin M Connolly, Fengmin Zhao, Kathy D Miller, et al.
Page
of 84
Search research articles
Search
Showing results (741-750 of 831) with videos related to
Sort By:
Page
of 84
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 6, 2019
TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer
Roisin M Connolly, Jeffrey P Leal, Lilja Solnes, et al.
Radiology
|
April 1, 2025
MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial)
Kalina P Slavkova, Ruya Kang, Anum S Kazerouni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 14, 2020
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
Kimberly H Allison, M Elizabeth H Hammond, Mitchell Dowsett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 2004
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004
Eric P Winer, Clifford Hudis, Harold J Burstein, et al.
Science Translational Medicine
|
June 8, 2012
A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma
Sharanya Sivanand, Samuel Peña-Llopis, Hong Zhao, et al.
Radiology
|
April 29, 2025
Erratum for: MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial)
Kalina P Slavkova, Ruya Kang, Anum S Kazerouni, et al.
Archives of Pathology & Laboratory Medicine
|
October 9, 2013
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2006
2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline
Thomas J Smith, James Khatcheressian, Gary H Lyman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2005
American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer
Gary H Lyman, Armando E Giuliano, Mark R Somerfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 6, 2021
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group
Roisin M Connolly, Fengmin Zhao, Kathy D Miller, et al.
Page
of 84